12
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Omeprazole, Cimetidine, and Ranitidine: Inhibition of Acid Production in Isolated Human Parietal Cells

, , , &
Pages 917-921 | Received 20 Dec 1984, Accepted 07 Feb 1985, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

DuckH. Suh & MohamedS. Abdel‐Rahman. (1997) Assessing human health risks of chemicals and drugs: An overview. Human and Ecological Risk Assessment: An International Journal 3:4, pages 599-615.
Read now
W. Creutzfeldt, R. Lamberts, F. Stöckmann & G. Brunner. (1989) Quantitative Studies of Gastric Endocrine Cells in Patients Receiving Long-term Treatment with Omeprazole. Scandinavian Journal of Gastroenterology 24:sup166, pages 122-128.
Read now

Articles from other publishers (6)

Dong-Seok Yim. (2019) Potency and plasma protein binding of drugs in vitro —a potentially misleading pair for predicting in vivo efficacious concentrations in humans . The Korean Journal of Physiology & Pharmacology 23:4, pages 231.
Crossref
Sonia Goineau & Vincent Castagné. (2017) Complementarity of in vitro and in vivo models for the evaluation of gastro-protective effects of pharmacological substances. Fundamental & Clinical Pharmacology 31:2, pages 155-164.
Crossref
J.E Cecil, J Francis & N.W Read. (2004) Investigation into the role of cephalic stimulation of acid secretion on gastric emptying and appetite following a soup meal using the gastric acid inhibitor omeprazole. Appetite 42:1, pages 99-105.
Crossref
Upjeet Kaur, Navneet Agnihotri, Simran Kaur, Madhu Khullar, Pradeep Bambery, Gagan Sood & Kartar Singh. (1995) Duodenal ulcer. Digestive Diseases and Sciences 40:4, pages 887-892.
Crossref
Herbert F. Helander. (1988) Physiology and pharmacology of the parietal cell. Baillière's Clinical Gastroenterology 2:3, pages 539-554.
Crossref
H. G. DAMMANN, TH. A. WALTER, M. DREYER, B. DAU, P. MÜLLER & B. SIMON. (2007) What are the current possibilities in treating peptic ulcer disease?. Alimentary Pharmacology & Therapeutics 1, pages 468s-492s.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.